Breakthrough Peptide Technology
Hybridtides® are a new class of drug candidates that deliver unique product profiles.
Preclinical Development
Longevity Biotech has multiple preclinical programs in development all based on the Hybridtide® core technology.
PipelineOral Peptide Delivery
Hybridtides® demonstrate robust durability in a variety of biological matrices. Absorption parameters are optimized via our proprietary databases.
Artisan Biology®
The unique composition of Hybridtides® (natural and non-natural amino acids) enables 'fine-tuning' of intracellular signal cascades. In other words, Hybridtides® demonstrate signal bias.
0
Peer Reviewed Papers
0
Citations
0
Patents
0
Preclinical Programs
0
Purpose
Contact Us
Info@LongevityBiotech.com
Office
600 South 43rd Street
Philadelphia, PA 19104
Phone
215.689.1042